The UK interstitial lung disease long COVID-19 study
Not Applicable
Completed
- Conditions
- COVID-19 (SARS-CoV-2 infection)Infections and Infestations
- Registration Number
- ISRCTN16650532
- Lead Sponsor
- Imperial College London
- Brief Summary
2021 Protocol article in https://pubmed.ncbi.nlm.nih.gov/34556492/ (added 02/11/2021)
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- All
- Target Recruitment
- 183
Inclusion Criteria
1. Aged 18 to 99 years old
2. Evidence of SARS-CoV-2 infection confirmed by PCR or serology 3 months (+/- 6 weeks) earlier
3. Clinical indication for a chest CT scan as per clinician judgment
4. Participants who have been identified and consented for the main PHOS-PCOVID study are also eligible to join this study
5. Allow inclusion of patients who are receiving up to 10 mg of prednisolone a day
Exclusion Criteria
1. Life-limiting illness within 12 months
2. Significant pre-existing lung disease prior to March 2020, which in the investigator’s judgement could make the chest CT scans difficult to interpret
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method